Back to Selection     Print       Date : 30 Apr 2026
Fund Summary
Tata India Pharma & HealthCare Fund Reg Plan (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Dec-15
Corpus(Cr.) 1325.0 Latest NAV 31.4136 As on 12-06-2026
Equity(%) 99.6 52 Week High 31.8131
Debt(%) 0.4 52 Week Low 27.913
Others(%) 0.0 Exit Load 0.25% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.21
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rajat Srivastava
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 31.78%
Top 10 Holdings 52.60%
Top 25 Holdings 90.94%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 58.72
Healthcare 35.02
Fertilisers 4.47
Chemicals 0.72
Miscellaneous 0.67
Cash 0.4
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.95
PE Ratio 42.24
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 9.87
DIVI LABORATORIES LTD 5.92
Healthcare Global Enterprises Limited 5.45
Abbott India Limited 5.37
Max Healthcare Institute Limited 5.17
Cipla Limited 5.07
Rainbow Childrens Medicare Limited 4.23
Apollo Hospitals Enterprise Limited 4.06
Dr Reddys Laboratories Limited 3.73
Mankind Pharma Limited 3.73
Fortis Health Care Ltd 3.55
Bayer Crop Science Ltd 3.34
Metropolis Healthcare Limited 3.07
Syngene International Limited 2.94
Lupin Limited 2.94
Sai Life Sciences Limited 2.63
Dr Lal Path Labs Ltd 2.60
Alkem Laboratories Limited 2.49
Glaxosmithkline Pharma Ltd 2.44
Neuland Laboratories Limited 2.41
J B Chemicals and Pharma Ltd 2.21
EQ- GLOBAL HEALTH LTD. 2.16
FDC Limited 1.94
Ajanta Pharma Limited 1.90
VIJAYA DIAGNOSTIC CENTRE LIMITED 1.72

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.83% 8.06% 3.22% 5.07%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
0.09% 2.31% -8.96% -3.41%
 
Scheme Benchmark [NSE - Nifty Pharma]
-1.03% 6.78% 6.89% 10.89%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
9.01% 21.78% 12.89% 13.15%
 
 
1.41% 9.21% 9.61% 12.64%
 
 
10.73% 23.42% 11.04% 8.50%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 17.06% 0.9892 11.1094% 44.3691 0.1408
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 13.9056% 0.0003 0.2672 14.5385 1.1409
 
Back to Selection